Home » All » Stock Forecast » Evommune Inc. Common Stock Forecast

Evommune Inc. Common Stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC
▲ +0.36%Market Cap $1.01B · Technical analysis Bullish · Focus area Price + volatility

Forecast Summary

TimeframePredicted PricePastHistoricalInsight
Tomorrow$27.87 -0.71%Yesterday$28.15 +0.30%Tomorrow's Evommune Inc. Common Stock (EVMN) setup is anchored to $28.07 and targets $27.87 (-0.71%). The near-term read is downside; watch $28.91 / $27.23 because daily realized volatility is about 3.65%.
Tomorrow's Evommune Inc. Common Stock (EVMN) setup is anchored to $28.07 and targets $27.87 (-0.71%). The near-term read is downside; watch $28.91 / $27.23 because daily realized volatility is about 3.65%.
Week$27.45 -2.20%Last Week$28.33 +0.92%The 7-day Evommune Inc. Common Stock model moves from $28.33 to $27.45 (-2.20%). It gives downside momentum context for this stock, so breaks around $28.91 / $27.23 matter more than a single tick.
The 7-day Evommune Inc. Common Stock model moves from $28.33 to $27.45 (-2.20%). It gives downside momentum context for this stock, so breaks around $28.91 / $27.23 matter more than a single tick.
Month$26.75 -4.69%Last Month$28.62 +1.97%The 1-month Evommune Inc. Common Stock target is $26.75 (-4.69%), compared with the live reference near $28.07. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Evommune Inc. Common Stock target is $26.75 (-4.69%), compared with the live reference near $28.07. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year$25.71 -8.41%Last Year$29.06 +3.53%The 1-year Evommune Inc. Common Stock scenario points to $25.71 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Evommune Inc. Common Stock scenario points to $25.71 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years$23.26 -17.14%5 Years Ago$30.09 +7.20%The 5-year Evommune Inc. Common Stock view is $23.26 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Evommune Inc. Common Stock view is $23.26 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Tomorrow$27.87 -0.71%
Yesterday$28.15 +0.30%
Tomorrow's Evommune Inc. Common Stock (EVMN) setup is anchored to $28.07 and targets $27.87 (-0.71%). The near-term read is downside; watch $28.91 / $27.23 because daily realized volatility is about 3.65%.
Week$27.45 -2.20%
Last Week$28.33 +0.92%
The 7-day Evommune Inc. Common Stock model moves from $28.33 to $27.45 (-2.20%). It gives downside momentum context for this stock, so breaks around $28.91 / $27.23 matter more than a single tick.
Month$26.75 -4.69%
Last Month$28.62 +1.97%
The 1-month Evommune Inc. Common Stock target is $26.75 (-4.69%), compared with the live reference near $28.07. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year$25.71 -8.41%
Last Year$29.06 +3.53%
The 1-year Evommune Inc. Common Stock scenario points to $25.71 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years$23.26 -17.14%
5 Years Ago$30.09 +7.20%
The 5-year Evommune Inc. Common Stock view is $23.26 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish
$28.71$28.26$27.80$27.35$26.901W AgoNow7D F

Technical Analysis

SellNeutralBuy
Neutral
1
Bullish
3
Neutral
1
Bearish

Key Indicators

IndicatorValueSignal
Price$28.07 Mid
Daily Change+0.36% Above
Volatility Cap20.0% Mid
Confidence58% Below
Data Sourcenasdaq-screener Mid

Historical Data

Current$28.07
Daily Change+0.36%
Market Cap$1.01B
Sourcenasdaq-screener
Current$28.07Daily Change+0.36%
Market Cap$1.01BSourcenasdaq-screener

Support & Resistance Levels

$27.23Support 1
$28.07Current
$28.91Resistance 1
i
Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context
Current$28.07Live reference price
Used as the anchor for generated forecast calculations.
Next Month$26.75Model projection-4.69%
Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed
58%
Directional
Generated market-data forecast
This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.
📊
Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.
Short term
58%
Direction confidence
Long term
Lower
Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in EVMN today
Bullish Scenario
$29.47
+5.00% from current
Target Price$29.47
ScenarioUpside momentum
Probability50%
Base Scenario
$26.75
-4.69%
Target Price$26.75
ScenarioCapped drift
Probability58%
Bearish Scenario
$26.67
-5.00% from current
Target Price$26.67
ScenarioVolatility drawdown
Probability42%
Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure
Price structure reflects the latest momentum regime and support/resistance interaction.
Momentum Bearish · 40/100
24H drift-0.71%
7D drift-2.20%
30D drift-4.69%
Technical Signals
Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.
Mixed — Watching · 50/100
RSIn/a
MACDn/a
MA stackn/a
Macro Context
Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.
Risk-Off Caution · 35/100
1M outlook-4.69%
1Y outlook-8.41%
5Y outlook-17.14%

Frequently Asked Questions

Q What is the Evommune Inc. Common Stock (EVMN) forecast for tomorrow?
Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Evommune Inc. Common Stock is projected near $27.87 versus the current reference around $28.07. That implies a modeled move of -0.71% over the next day, with realized prices still sensitive to intraday volatility.
Q What does the 7-day stock outlook suggest for EVMN?
The weekly Evommune Inc. Common Stock model points to $27.45, which maps to an expected drift of -2.20% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.
Q How should I read the Evommune Inc. Common Stock 1-month and 1-year targets?
The Evommune Inc. Common Stock 1-month target is $26.75 (-4.69%), while the 1-year target is $25.71 (-8.41%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.
Q Why does the Evommune Inc. Common Stock 5-year scenario differ from short-term rows?
The Evommune Inc. Common Stock long-horizon scenario sits near $23.26 with a modeled change of -17.14%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.
Q Where are EVMN support and resistance zones right now?
For Evommune Inc. Common Stock, nearest resistance is around $27.23, while nearest support is around $28.91. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.
Q How fresh is the Evommune Inc. Common Stock market snapshot?
The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.
Evommune Inc. Common Stock Forecast 2026 – Tomorrow, Week & Month